✉news HealthMedicine first seen 7 d ago, last 7 d ago, peak #33
First Participants Dosed in Phase 1 Trial of Alzheimer's Vaccine Candidate AV-1980R
Original: Institute for Molecular Medicine and Nuravax Announce First Participants Dosed in Phase 1 TAURUS-1980 Study of AV-1980R
The Institute for Molecular Medicine and Nuravax have announced that the first participants have been dosed in TAURUS-1980, a Phase 1 clinical trial of AV-1980R. The early-stage study marks the first time the vaccine candidate has been tested in humans, a key step toward evaluating its safety and immune response. Details on trial size, locations and timelines have not yet been widely reported.
Why now: The announcement of first human dosing is a notable early milestone for a new vaccine candidate, drawing attention from the medical and biotech communities.
Institute for Molecular MedicineNuravaxAV-1980RTAURUS-1980
Evidence
- Institute for Molecular Medicine and Nuravax Announce First Participants Dosed in Phase 1 TAURUS-1980 Study of AV-1980R · PR Newswire
API: https://socialmediatrends-api.osmike.com/v1/trends/1395084